MORE►
NIH
Dallas-Fort Worth Biotech Targets Cancer’s ‘Achilles Heel’ with Nanotechnology
by Nicole Ward, DRC Data Journalist | Aug 1, 2024
OncoNano's innovative approach to cancer treatment leverages nanotechnology to bring tumors into the light.
by Quincy Preston and Lance Murray |
Oct 20, 2023
The Advanced Research Projects Agency for Health—or ARPA-H— wants to enable 90% of eligible Americans to participate in clinical trials within 30 minutes of their homes. The agency officially launched its new Texas "customer experience" headquarters at Dallas' Pegasus Park on Thursday, which will be home base for the initiative.
MORE►
by David Seeley |
Sep 18, 2023
The award will help SMU biology professor Zhihao Wu determine if different "quality control pathways" in our bodies might be working together to repair damaged components in cells. The research could help lead to "new therapeutic targets" for hallmarks known to cause many human diseases, the university said.
MORE►
by Dallas Innovates | Staff Report |
Jul 14, 2023
A holder of 34 patents, Sherry was a pioneer in designing molecular materials for use in medical imaging. His work on chemicals called macrocyclic ligands led to their use in carrying "a payload of metallic radiotherapeutic compounds that can kill cancer cells on contact, while the outside molecular structure can be designed to bind to a specific protein that ensures precise delivery to only diseased tissue," Amanda Siegfried writes in UT Dallas Magazine.
MORE►
From left: Avsana Labs' Dr. Zhenpeng Qin, associate professor of mechanical engineering; mechanical engineering doctoral student Yaning Liu; and Dr. Haihang Ye, research associate in mechanical engineering, are part of a team working to commercialize technology for a rapid virus test they've developed. [Photo: UT Dallas]
UTD Team Develops Rapid Virus Test That’s ‘150 Times More Accurate’—and They’ve Launched a Company to Commercialize It
by David Seeley | Apr 21, 2022
A team of UT Dallas bioengineers has developed a rapid test for viruses that delivers results as accurate as PCR lab tests within 30 minutes. The test works by attaching gold nanoparticles to antibodies against the virus being tested, then scanning them with two lasers.
Three months after winning the grand prize at the MassChallenge North Texas pitch competition, the team's leader, Dr. Zhenpeng Qin, is working to commercialize the technology through a new company, Avsana Labs.
Three months after winning the grand prize at the MassChallenge North Texas pitch competition, the team's leader, Dr. Zhenpeng Qin, is working to commercialize the technology through a new company, Avsana Labs.
MORE►
by David Seeley |
Oct 7, 2021
The award from the National Institutes of Health will help HSC lead the AI/Machine Learning Consortium to Advance Health Equity and Researcher Diversity, or AIM-AHEAD, program. The effort will bring together experts in community engagement, AI/ML, health equity research, data science training, and data infrastructure.
MORE►
by Alex Edwards |
Jun 1, 2020
DesignPlex Biomedical was given a royalty-free license by NASA to commercialize a new ventilator for coronavirus patients. Nanoscope Technologies got more than $2 million from the National Eye Institute to advance its gene therapy treatment.
MORE►
by Dave Moore |
Apr 27, 2018
Local startups and researchers can learn how to get federal research-and-tech-driven grant funding and meet federal experts in this conference hosted by the Dallas Regional Chamber.
MORE►
